Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Učinkovitost in najpogostejši neželeni učinki zdravljenja z zaviralci od ciklina odvisnih kinaz 4 in 6 (CDK 4/6) pri metastatskem raku dojke
Authors:ID Privšek, Nina (Author)
ID Grašič-Kuhar, Cvetka (Author)
Files:.pdf PDF - Presentation file, download (158,51 KB)
MD5: B0241FAEEE558170A398C3335F41EBC4
 
Language:Slovenian
Typology:1.03 - Other scientific articles
Organization:Logo OI - Institute of Oncology
Abstract:dZaviralci od ciklina odvisnih kinaz (CDK)4/6 so relativno nova tarčna zdravila pri raku dojk, ki jih uporabljamo pri hormonsko odvisnem HER-2 negativnem podtipu za bolnice z lokalno napredovalim ali razsejanim rakom. V registracijskih kliničnih raziskavah, kot tudi v vsakodnevni praksi, so se izkazali za učinkovita zdravila s sprejemljivim varnostnim profilom. V spodnjem prispevku bomo na kratko predstavili učinkovitost in najpogostejše neželene učinke zdravljenja z zaviralci CDK4/6 ter ukrepanje ob njihovem pojavu.
Keywords:zaviralci CDK4/6, palbociklib, ribociklib, abemaciklib, neželeni učinki
Publication status:Published
Publication version:Version of Record
Publisher:Onkološki inštitut Ljubljana
Year of publishing:2021
Number of pages:str. 48-53
Numbering:Letn. 25, št. 2
PID:20.500.12556/DiRROS-14658 New window
UDC:616-006
ISSN on article:1408-1741
COBISS.SI-ID:88612099 New window
Copyright:by Authors
Publication date in DiRROS:14.12.2021
Views:1386
Downloads:379
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija
Shortened title:Onkologija
Publisher:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:01.12.2021

Secondary language

Language:Slovenian
Title:Overview of the efficacy and most common side effects of treatment with cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitors in metastatic breast cancer


Collection

This document is a part of these collections:
  1. Onkologija : strokovni časopis za zdravnike

Back